Details for New Drug Application (NDA): 090022
✉ Email this page to a colleague
The generic ingredient in ALENDRONATE SODIUM is alendronate sodium. There are twenty-five drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the alendronate sodium profile page.
Summary for 090022
Tradename: | ALENDRONATE SODIUM |
Applicant: | Sun Pharm |
Ingredient: | alendronate sodium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 090022
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Sep 10, 2008 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Sep 10, 2008 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 35MG BASE | ||||
Approval Date: | Sep 10, 2008 | TE: | AB | RLD: | No |
Complete Access Available with Subscription